Numerous retrospective investigations have examined the possibility that COX-2 overexpression may be a predictive factor for survival in individuals with colorectal cancer [[11], [12], [13]], showing that poor prognosis is associated with high COX-2 levels in tumour tissue, whether in the tumour cells or the stroma compartment [12,13]. This evidence concerns the gene PTGS2 and neoplasm.